CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 146 filers reported holding CASSAVA SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,712 | +1.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14,472 | -18.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,724 | -29.1% | 600 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $25,000 | +47.1% | 600 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $17,000 | -22.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | -15.4% | 600 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $26,000 | +116.7% | 600 | +200.0% | 0.00% | +200.0% |
| Q3 2021 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |